ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.56
-0.32%
US Tech 100
19,168.20
-0.04%
S&P 500
5,463.20
-0.11%
US Dollar vs CAD
1.36943
0.24%
Bitcoin
61,449.93
-0.58%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Lexaria Bioscience Corporation (LEXXW)

  7. Lexaria Bioscience Corporation (LEXXW) News

LEXXW

Lexaria Bioscience (LEXXW)

Lexaria Bioscience Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:LEXXW
DateTimeSourceHeadlineSymbolCompany
06/11/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LEXXWLexaria Bioscience Corporation
06/11/20244:00PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:LEXXWLexaria Bioscience Corporation
06/03/202412:05PMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:LEXXWLexaria Bioscience Corporation
05/15/20244:37PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LEXXWLexaria Bioscience Corporation
05/10/20244:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LEXXWLexaria Bioscience Corporation
05/10/20244:16PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LEXXWLexaria Bioscience Corporation
05/10/20244:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LEXXWLexaria Bioscience Corporation
05/10/20243:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LEXXWLexaria Bioscience Corporation
07/22/20217:18AMInvestorsHub NewsWireLexaria Summarizes Successful Antiviral Drug Studies and Ongoing StrategyNASDAQ:LEXXWLexaria Bioscience Corporation
07/21/20216:27AMInvestorsHub NewsWireLexaria's DehydraTECH Significantly Enhances Delivery of Colchicine in Study VIRAL-A20-3NASDAQ:LEXXWLexaria Bioscience Corporation
07/15/20217:14AMInvestorsHub NewsWireLexaria Completes Successful Antiviral Drug Molecular Characterization Study With Canada's National Research CouncilNASDAQ:LEXXWLexaria Bioscience Corporation
06/03/20217:05AMInvestorsHub NewsWireLexaria's DehydraTECH(TM)-Enabled Remdesivir and Ebastine Effectively Inhibit the COVID-19 SARS-CoV-2 VirusNASDAQ:LEXXWLexaria Bioscience Corporation
05/20/20216:16AMInvestorsHub NewsWireLexaria's Newest DehydraTECHTM 2.0 Formulation Tested in Study HYPER-A21-2 Demonstrates Its Strongest CBD Absorption..contNASDAQ:LEXXWLexaria Bioscience Corporation
05/12/20216:18AMInvestorsHub NewsWireLexaria Strengthens its International Patent Portfolio to 19 Patents GrantedNASDAQ:LEXXWLexaria Bioscience Corporation
05/06/20216:35AMInvestorsHub NewsWireLexaria Issues Successful Results from First 2021 Study, HYPER-A21-1NASDAQ:LEXXWLexaria Bioscience Corporation
04/14/20216:37AMInvestorsHub NewsWireLexaria's DehydraTECHTM Technology Utilized in Amari's "Everyday Calm," Named a Top CBD Product Pick by New Hope NetworkNASDAQ:LEXXWLexaria Bioscience Corporation
04/06/20216:16AMInvestorsHub NewsWireLexaria to Evaluate DehydraTECHTM in Multiple New MarketsNASDAQ:LEXXWLexaria Bioscience Corporation
03/24/20217:00AMInvestorsHub NewsWireLexaria Technology Generates Positive Stability Testing for World-Class Ready to Drink CBD BeveragesNASDAQ:LEXXWLexaria Bioscience Corporation
03/16/20216:39AMInvestorsHub NewsWireLexaria's Antiviral Drug Evaluation Program ProgressingNASDAQ:LEXXWLexaria Bioscience Corporation
03/15/20217:30AMInvestorsHub NewsWireRapid Progress in Hypertension Studies by LexariaNASDAQ:LEXXWLexaria Bioscience Corporation
 Showing the most relevant articles for your search:NASDAQ:LEXXW

Your Recent History

COIN
CDASHUST
CryptoDash Token
EU
FPG
Union Tech Info
USOTC
SCGY
Scientific Energy (PK)
ASE
PROF
Profile Systems and Soft...
NASDAQI
CLESGBRT
CRSP ISS US Large Cap ES...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved